MedPath

An exploratory study to identify the factors related to recurrence of Generalized Pustular Psoriasis (GPP) flare in adult patients with GPP in Japa

Not Applicable
Conditions
Generalized Pustular Psoriasis (GPP)
Registration Number
JPRN-UMIN000052793
Lead Sponsor
ippon Boehringer Ingelheim Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
205
Inclusion Criteria

Not provided

Exclusion Criteria

-Patients who have been diagnosed with paediatric GPP, impetigo herpetiformis, or other categories of GPP -Patients who have been diagnosed with unknown disease categories of GPP

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome: Recurrence of GPP flares in patients who experienced a GPP flare at baseline Time Frame: From the date of onset of the baseline GPP flare to the date of recurrence of a GPP flare or to the end of the follow-up Event: Recurrence of GPP flares confirmed by the Data Review Committee
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath